This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Manitoba directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $120,000
Investigation of Borsantrazole(TM) in multiple disease models
CIHR · 2026 · Supervisor
- $134,249
A Zetaview Multiple Parameter Particle Tracking System for Bioparticle and Nanobubble Research
NSERC · 2025 · Co-investigator
- $730,576
Development of a biomarker-driven 'best-in-class' treatment for amyotrophic lateral sclerosis: Discovery and proof-of-concept
CIHR · 2024 · Nominated PI
Investigation of Borsantrazole(TM) in multiple disease models
Principal investigators: Roghzai, Hemin H
Keywords: Alzheimer'S; Amyotrophic Lateral Sclerosis; Borsantrazole; Drug Development; Neurodegeneration; Parkinson'S
A Zetaview Multiple Parameter Particle Tracking System for Bioparticle and Nanobubble Research
Principal investigators: Bay, Denice
Keywords: membrane vesicles; lipid particles; virus-like particles; bacterial membranes; particle size determination; zeta potential; particle concentration measurement; biomembranes; fluorescence; green fluorescent protein
Development of a biomarker-driven 'best-in-class' treatment for amyotrophic lateral sclerosis: Discovery and proof-of-concept
Principal investigators: Tranmer, Geoffrey
Keywords: Amyotrophic Lateral Sclerosis; Antioxidants; Biomarker-Driven; Boron Medicinal Chemistry; Edaravone; Nsc-34 Cell Lines; Primary Cortical Neuron Culture; Sod1; Sod1-G37r Mouse Model
Boron Chemical Biology: Synthesis, Properties and Applications
Principal investigators: Tranmer, Geoffrey
Keywords: boron; boron functional groups; chemical biology; photocatalysis; synthetic organic methods; flow chemistry; microwave synthesis; drug discovery; boronic acids
Development of novel agents for the treatment of amyotrophic lateral sclerosis: Discovery and proof-of-concept
Principal investigators: Tranmer, Geoffrey
Keywords: Amyotrophic Lateral Sclerosis; Antioxidants; Boron Medicinal Chemistry; Edaravone; Nsc-34 Cell Lines; Primary Cortical Neuron Culture; Sod1; Sod1-G37r Mouse Model
FlowCoV: Development of Flow Chemistry Methods Related to COVID-19_x000d_
Principal investigators: Tranmer, Geoffrey
Development of Flow Chemistry Techniques: Resolution of Problematic Industrial Process Chemistry Reactions
Principal investigators: Tranmer, Geoffrey
Development of Novel Synthetic Methods Using Flow Chemistry Techniques
Principal investigators: Tranmer, Geoffrey
Identification and development of an industry partnership for the invention of diagnostic tools to address antimicrobial resistance
Principal investigators: Tranmer, Geoffrey; Ho, Emmanuel
Keywords: Antimicrobial Resistance; Microfluidic Diagnostics
Development of a New Partnership to Address Flow Chemistry in GMP Production
Principal investigators: Tranmer, Geoffrey
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.